Pfizer supplies UKHSA's adult SARS-CoV-2 vaccines for 2027
- UK Health Security Agency
- London
- Call-off from a dynamic purchasing system, 3 bids
- 21 September 2026 to 20 December 2027
The UK Health Security Agency (UKHSA) is buying adult SARS-CoV-2 vaccines for 2027 from Pfizer Ltd.
UKHSA ordered the vaccines through the SARS-CoV-2 vaccine DPS, as lot 1 of a further competition that drew three bids. Bids were judged on overall economy plus social value, waste reduction, security of supply, programme responsiveness and vaccine deployment.
Pfizer was chosen in September 2026, and the contract runs to December 2027. Its value was withheld from publication to protect Pfizer's commercial interests.
Contract ends December 2027
- What
- Vaccines and immunisation products
- Supplier
- Pfizer Ltd
- Value
- Not published
- How it was bought
- Call-off from a dynamic purchasing system
- 3 bids
- Dates and next
- Sep 2026 to Dec 2027
- Being re-tendered now